In this setting, patient 12, showing SD as the best response upon treatment with MVX-ONCO-1, subsequently received nivolumab despite negative PD-L1 expression on tumor cells and the tumor microenvironment (CPS = 0). The gene discussed is CD274; the disease is neoplasm.